Literature DB >> 4813244

Disposition of hydralazine in man and a specific method for its determination in biological fluids.

S B Zak, M F Bartlett, W E Wagner, T G Gilleran, G Lukas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4813244     DOI： 10.1002/jps.2600630210

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  5 in total

1.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of hydralazine.

Authors:  T M Ludden; J L McNay; A M Shepherd; M S Lin
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

3.  Disposition and metabolism of 3-hydrazino-6-[N,N-bis(2-hydroxyethyl)amino] pyridazine dihydrochloride in man.

Authors:  A Assandri; A Perazzi; G Buniva; V Pagani
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

4.  Studies on hydralazine. III. Bioavailability of hydralazine in man.

Authors:  T Talseth
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

5.  Studies on hydralazine. II. Elimination rate and steady-state concentration in patients with impaired renal function.

Authors:  T Talseth
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.